Summary
The specific binding of 3H-quipazine to putative 5-HT3 receptors was analyzed in multiple species. Specific and saturable binding of the radioligand could be detected in both rat (K D = 1.2 nM; B max = 3.0 pmol/g) and pig (K D = 1.3 ± 0.2 nM; B maX = 1.5 ± 0.2 p/mol/g) cortical membranes. By contrast, no significant specific binding of 3H-quipazine could be detected in human, cow, dog, turtle, mouse, guinea pig, chicken or rabbit brain membranes. These data indicate that marked species variations exist in the presence and/or density of 5-HT3 membrane recognition sites in the central nervous system.
Similar content being viewed by others
References
Heuring RE, Schlegel JR, Peroutka SJ (1986) Species variations in RU 24969 interactions with non-5-HT1A binding sites. Eur J Pharmacol 122:279–282
Hoyer D, Pazos A, Probst A, Palacios JM (1986) Serotonin receptors in the human brain. I. Characterization and autoradiographic localization of 5-HT1A recognition sites. Apparent absence of 5-HT1B recognition sites. Brain Res 376:85–96
Hoyer D, Neijt HC (1987) Identification of serotonin 5-HT3 recognition sites by radioligand binding in NG108–15 neuroblastoma-glioma cells. Eur J Pharmacol 143:291–292
Hoyer D, Neijt HC (1988) Identification of serotonin 5-HT3 recognition sites in membranes of N1E-115 neuroblastoma cells by radioligand binding. Mol Pharmacol 33:303–309
Ireland SJ, Tyers MB (1987) Pharmacological characterization of 5-hydroxytryptamine-induced depolarization of the rat isolated vagus nerve. Br J Pharmacol 90:229–238
Kilpatrick GJ, Jones BJ, Tyers MB (1987) Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding. Nature 330:746–748
Milburn CM, Hamik A, Peroutka SJ (1988) 3H-Quipazine labels 5-hydroxytryptamine3 receptors in rat cortical membranes. Soc Neurosci Abs 14:610
Neijt HC, Vijverberg HPM, Van Den Bercken J (1986) The dopamine response in mouse neuroblastoma cells is mediated by serotonin 5-HT3 receptors. Eur J Pharmacol 127:271–274
Peroutka SJ, Hamik A (1988) [3H]Quipazine labels 5-HT3 recognition sites in rat cortical membranes. Eur J Pharmacol 148:297–299
Richardson BP, Engel G (1986) The pharmacology and function of 5-HT3 receptors. Trends Neurosci 7:424–428
Richardson BP, Engel G, Donatsch P, Stadler PA (1985) Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs. Nature 316:126–131
Round A, Wallis DI (1987) Further studies on the blockade of 5-HT depolarizations of rabbit vagal afferent and sympathetic ganglion cells by MDL 72222 and other antagonists. Neuropharmacology 26:39–48
Waeber C, Dixon K, Hoyer D, Palacios JM (1988) Localisation by autoradiography of neuronal 5-HT3 receptors in the mouse CNS. Fur J Pharmacol 151:351–352
Watling KJ, Aspley S, Swain CJ, Saunders J (1988) [3H]Quaternised ICS 205–930 labels 5-HT3 receptors binding sites in rat brain. Eur J Pharmacol 149:397–398
Yagaloff KA, Hartig PR (1985) 125I-lysergic acid diethylamide binds to a novel serotonergic site on rat choroid plexus epithelial cells. J Neurosci 12:3178–3183
Author information
Authors and Affiliations
Additional information
Send offprint requests to Stephen J. Peroutka at the above address
Rights and permissions
About this article
Cite this article
Peroutka, S.J. Species variations in 5-HT3 recognition sites labeled by 3H-quipazine in the central nervous system. Naunyn-Schmiedeberg's Arch Pharmacol 338, 472–475 (1988). https://doi.org/10.1007/BF00179316
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF00179316